ClearPoint Neuro (CLPT) vs Avita Medical (RCEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Avita Medical (RCEL) has outperformed ClearPoint Neuro (CLPT) over the past year, gaining 138.6% versus a loss of 59.6%. Over five years, RCEL leads with a -24.9% price change compared with -40.6% for CLPT. Avita Medical is the larger company by market cap ($412.3 million vs $320.0 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLPT | RCEL |
|---|---|---|
| Share price | $10.49 | $13.33 |
| Market cap | $319.99M | $412.25M |
| 1-day change | -1.59% | +2.15% |
| YTD return | -22.08% | +278.26% |
| 1-year return | -59.61% | +138.57% |
| 5-year return | -40.65% | -24.87% |
| EPS (TTM) | $-1.18 | $-1.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.10 | $13.50 |
| 52-week low | $8.27 | $3.22 |
| Distance from 52-week high | -65.15% | -1.26% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +124.02% | -9.75% |
| Average volume | 637.17K | 441.70K |
| Shares outstanding | 30.50M | 30.93M |
| Employees | 160 | 226 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RCEL has outperformed CLPT by 198.2 percentage points over the past year.
About ClearPoint Neuro
CLPT stock →ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.
Health Care · Medical/Dental Instruments · 160 employees
About Avita Medical
RCEL stock →AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Health Care · Medical/Dental Instruments · 226 employees
CLPT vs RCEL FAQ
Which is bigger, ClearPoint Neuro or Avita Medical?
Avita Medical (RCEL) is larger, with a market capitalization of $412.25M compared with $319.99M for ClearPoint Neuro (CLPT).
Which stock has performed better over the past year, CLPT or RCEL?
RCEL returned +138.57% over the past 12 months, compared with -59.61% for CLPT (price return, excluding dividends). Past performance does not predict future results.
Are ClearPoint Neuro and Avita Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.